Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | MIF | P14174 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21546125 | 0.91 | MAPT (0.42) | SMN1; SMN2MAPTKMT2AKDM4EATM | |
| SCHEMBL16587928 | 0.87 | — | — | |
| SCHEMBL4612793 | 0.87 | — | — | |
| SCHEMBL15929785 | 0.87 | — | — | |
| SCHEMBL1385858 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL27755494 | 0.81 | SMN1; SMN2 (0.40) | SMN1; SMN2MAPTKMT2AKDM4EATM | |
| Cyclopropanecarboxylic Acid Amide SCHEMBL5661 | 0.78 | — | — | |
| SCHEMBL9797557 | 0.78 | SMN1; SMN2 (0.50) | SMN1; SMN2MAPTKMT2AKDM4EATM | |
| Cyclopropanecarboxylic Acid Amide SCHEMBL6927157 | 0.78 | SMN1; SMN2 (0.50) | SMN1; SMN2MAPTKMT2AKDM4EATM | |
| SCHEMBL28418543 | 0.78 | SMN1; SMN2 (0.50) | SMN1; SMN2MAPTKMT2AKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1856297-A | Pharmaceutical composition for solubility enhancement of hydrophobic drugs | SANDOZ AG (CH) | 2006-11-01 | — | — | CN | claimed |
| WO-2026098567-A1 | MACROCYCLIC COMPOUNDS AND USE THEREOF | 微境生物医药科技(上海)有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-1856297-A | Pharmaceutical composition for solubility enhancement of hydrophobic drugs | SANDOZ AG (CH) | 2006-11-01 | — | — | CN | disclosed |
| EP-1596844-A2 | USE OF SODIUM CHANNEL MODULATORS FOR TREATING GASTROINTESTINAL TRACT DISORDERS | Dynogen Pharmaceuticals Inc. (US) | 2005-11-23 | — | — | EP | disclosed |
| WO-2004066987-A2 | USE OF SODIUM CHANNEL MODULATORS FOR TREATING GASTROINTESTINAL TRACT DISORDERS | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-08-12 | — | — | WO | disclosed |
| US-5760246-A | ANTILIPEMIC AGENTS, ANTICHOLESTEROL AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 1998-06-02 | — | — | US | disclosed |
| EP-0012523-A1 | Therapeutic compositions with enhanced bioavailability and process for their preparation | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-06-25 | — | — | EP | disclosed |